The iShares U.S. Healthcare ETF Starts 2022 in a Bearish Fashion

The iShares U.S. Healthcare ETF added more than 20% to its value last year but has started 2022 in a bearish fashion.

IYF Dips by More Than 1.5% in 24 Hours

The iShares U.S. Healthcare ETF lost more than 1.5% of its value during Tuesday’s trading session. The fund performed excellently last year as healthcare stocks took center stage in the United States but is struggling so far in 2022.

The ETF provides investors with broad exposure to the Healthcare – Broad segment of the United States stock market. It is a passively managed fund that has been around since 2000. The iShares U.S. Healthcare ETF is managed by BlackRock and has more than $3.2 billion in assets under management, making it one of the larger ETFs attempting to match the performance of the Healthcare – Broad segment of the stock market.

The fund seeks to track the performance of the Dow Jones U.S. Health Care Index before fees and expenses. This index measures the performance of the healthcare sector of the U.S. stock market.

IYH has annual expenses of 0.41%, making it on par with most peer products in the space, while the 12-month trailing dividend yield is 0.94%.

IYH Could Recover From Recent Slump

IYH is currently trading at $292.95, down 1.56% during the previous trading session. The ETF’s three biggest holdings are Johnson & Johnson (JNJ), Unitedhealth Group Inc (UNH) and Thermo Fisher Scientific Inc (TMO).

The fund’s technical indicators show that it is still performing well. IYH is trading above its 50-day moving average price of $287 per share. Meanwhile, the MACD line is still within the positive territory, while the RSI of 59 shows that there is still a buying pressure on IYH.

If the bulls regain control, IYH could break past the resistance level at $301 during the next trading session. An extended bullish performance would allow IYH to move past the second major resistance level at $309.